Success and complication rates of lead extraction with the first- vs. the second-generation Evolution mechanical sheath

被引:20
|
作者
Witte, Olivier A. [1 ]
Adiyaman, Ahmet [1 ]
Smit, Jaap Jan J. [1 ]
Misier, Anand R. Ramdat [1 ]
Elvan, Arif [1 ]
Ghani, Abdul [1 ]
Delnoy, Peter Paul H. M. [1 ]
机构
[1] Isala Heart Ctr, Dept Cardiol, Dr Van Heesweg 2, NL-8025 AB Zwolle, Netherlands
来源
EUROPACE | 2017年 / 19卷 / 10期
关键词
Lead extraction; Implantable cardioverter-defibrillator; Pacemaker; Complications; CARDIOVERTER-DEFIBRILLATOR LEADS; SINGLE-CENTER EXPERIENCE; DILATOR SHEATH; PACEMAKER; SAFETY; LASER;
D O I
10.1093/europace/euw255
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims The Evolution sheath (Cook Medical, USA) is a power sheath frequently used for chronic lead extraction. In 2013, a novel type (bidirectional) of Evolution sheath (the RL type) was introduced. We evaluated differences in success and complication rates of the two types. Methods and reults From 2009 to 2015, all lead extractions requiring the use of an Evolution sheath were prospectively examined. According to the current guidelines, complete procedural success was defined as the removal of all targeted lead materials. Clinical success was the retention of a small portion of the lead, and failure was the inability to achieve either complete procedural or clinical success or the development of any permanently disabling complication. The Evolution sheath was used to extract 149 leads in 103 patients. The first 56 leads were extracted with the original unidirectional sheath, and 93 leads were extracted with the novel bidirectional R/L type. The median age of the lead at the time of extraction was 6.8 vs. 9.1 years (P = 0.007). Complete procedural success was higher for the Evolution R/L (80.0 vs. 98%, P = 0.0004). Clinical success rate was 98 vs. 99%. There were no major complications and 6 (12.0%) vs. 2 (3.8%) minor complications (P = 0.153). We did not observe changes in success rates or complications over time, meaning that the difference cannot be explained by learning curve. Conclusion Use of the novel Evolution R/L sheath vs. the original Evolution sheath was associated with significant higher complete success rates, without major complications and with a trend towards the reduction of minor complications.
引用
收藏
页码:1717 / 1722
页数:6
相关论文
共 41 条
  • [1] Success and complication rates of lead-extraction with the first versus the second generation Evolution mechanical sheath
    Delnoy, P. P. H. M.
    Witte, O. A.
    Adiyaman, A.
    Smit, J. J. J.
    Misier, A. R. Ramdat
    Elvan, A.
    Ghani, A.
    [J]. EUROPEAN HEART JOURNAL, 2017, 38 : 371 - 371
  • [2] Endometrial ablation: first- vs. second-generation techniques
    Angioni, Stefano
    Pontis, Alessandro
    Nappi, Luigi
    Sedda, Federica
    Sorrentino, Felice
    Litta, Pietro
    Haimovich, Sergio
    Melis, Gian B.
    [J]. MINERVA GINECOLOGICA, 2016, 68 (02): : 143 - 153
  • [3] Hip fractures in users of first- vs. second-generation bisphosphonates
    Mamdani, M.
    Kopp, A.
    Hawker, G.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2007, 18 (12) : 1595 - 1600
  • [4] Hip fractures in users of first- vs. second-generation bisphosphonates
    M. Mamdani
    A. Kopp
    G. Hawker
    [J]. Osteoporosis International, 2007, 18 : 1595 - 1600
  • [5] First- vs second-generation antipsychotic drugs in schizophrenia
    Andrade, Chittaranjan
    Kharawala, Saifuddin
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2007, 64 (08) : 978 - 979
  • [6] First- vs second-generation antipsychotic drugs in schizophrenia - In reply
    Jones, Peter B.
    Barnes, Thomas R. E.
    Elton, Peter
    Davies, Linda
    Dunn, Graham
    Lloyd, Helen
    Hayhurst, Karen P.
    Murray, Robin M.
    Marwick, Alison
    Lewis, Shon
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2007, 64 (08) : 979 - 980
  • [7] Electronically monitored adherence in outpatients with schizophrenia or schizoaffective disorder: A comparison of first- vs. second-generation antipsychotics
    Nakonezny, PA
    Byerly, MJ
    [J]. SCHIZOPHRENIA RESEARCH, 2006, 82 (01) : 107 - 114
  • [8] First- vs Second-generation antipsychotics in psychotic disorders: Efficacy and tolerability issues
    Flirski, M.
    Magierski, R.
    Sobow, T.
    Kloszewska, I.
    [J]. EUROPEAN PSYCHIATRY, 2008, 23 : S169 - S169
  • [9] Long-Term Outcomes with First- vs. Second-Generation Drug-Eluting Stents in Saphenous Vein Graft Lesions
    Pokala, Nagendra R.
    Menon, Rohan V.
    Patel, Siddharth M.
    Christopoulos, George
    Christakopoulos, Georgios E.
    Kotsia, Anna P.
    Rangan, Bavana V.
    Roesle, Michele
    Abdullah, Shuaib
    Grodin, Jerrold
    Kumbhani, Dharam J.
    Hastings, Jeffrey
    Banerjee, Subhash
    Brilakis, Emmanouil S.
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2016, 87 (01) : 34 - 40
  • [10] Elevated mutation rates in the germ line of first- and second-generation offspring of irradiated male mice
    Barber, R
    Plumb, MA
    Boulton, E
    Roux, I
    Dubrova, YE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (10) : 6877 - 6882